Compare · BSX vs MMED
BSX vs MMED
Side-by-side comparison of Boston Scientific Corporation (BSX) and MiniMed Group Inc. (MMED): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BSX and MMED operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- BSX is the larger of the two at $62.46B, about 9.9x MMED ($6.31B).
- Over the past year, BSX is down 58.7% and MMED is up 22.9% - MMED leads by 81.6 points.
- MMED has been more active in the news (7 items in the past 4 weeks vs 4 for BSX).
- BSX has more recent analyst coverage (25 ratings vs 13 for MMED).
- Company
- Boston Scientific Corporation
- MiniMed Group Inc.
- Price
- $43.09-4.19%
- $22.43-1.43%
- Market cap
- $62.46B
- $6.31B
- 1M return
- -15.83%
- +13.59%
- 1Y return
- -58.70%
- +22.86%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2026
- News (4w)
- 4
- 7
- Recent ratings
- 25
- 13
Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Latest BSX
- SEC Form 8-K filed by Boston Scientific Corporation
- SEC Form 4 filed by Boston Scientific Corporation
- Director Morano Susan E bought $100,408 worth of shares (2,040 units at $49.22), increasing direct ownership by 17% to 13,784 units (SEC Form 4)
- Boston Scientific Corporation filed SEC Form 8-K: Other Events
- SEC Form 4 filed by SVP, Global Controller and CAO Woodworth Emily
- SEC Form 4 filed by EVP and CFO Monson Jonathan
- Boston Scientific announces participation in Wells Fargo 21st Annual Healthcare Conference and conference call discussing third quarter 2026 results
- Director Habiger David C bought $99,937 worth of shares (2,100 units at $47.59), increasing direct ownership by 14% to 17,160 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Boston Scientific Corporation
- Director Habiger David C bought $56,887 worth of shares (1,182 units at $48.13), increasing direct ownership by 9% to 15,060 units (SEC Form 4)
Latest MMED
- SEC Form 10-Q filed by MiniMed Group Inc.
- MiniMed Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- MiniMed Delivers Strong Start to Fiscal Year 2027 with U.S. Growth Acceleration
- MiniMed to Participate in Upcoming Investor Conferences
- SEC Form DEFA14A filed by MiniMed Group Inc.
- SEC Form DEF 14A filed by MiniMed Group Inc.
- MiniMed's Smallest App-Controlled Insulin Pump Now Shipping with the World's Smallest Sensor
- MiniMed Group Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SVP, Gen. Counsel, Corp. Sec. Wills Courtney Nelson covered exercise/tax liability with 1,762 shares, decreasing direct ownership by 1% to 136,384 units (SEC Form 4) (withholding tax)
- EVP Ch. Prod. & Tech Officer Dianaty Ali covered exercise/tax liability with 8,012 shares, decreasing direct ownership by 2% to 315,158 units (SEC Form 4) (withholding tax)